Formation of translational risk score based on correlation coefficients as an alternative to Cox regression models for predicting outcome in patients with NSCLC

Theoretical Biology and Medical Modelling

Volumn 8, Issue 1, 2011, Pages

  Kössler, Wolfgang ^a   Fiebeler, Anette ^b   Willms, Arnulf ^c   Elaidi, Tina ^d   Klosterhalfen, Bernd ^e   Klinge, Uwe ^d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Surgical Department   (Germany)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e Hospital of Duren   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; GROWTH ARREST SPECIFIC PROTEIN 6; GROWTH ARREST-SPECIFIC PROTEIN 6; LEUKOCYTE ANTIGEN; SIGNAL PEPTIDE;

AGED; AREA UNDER THE CURVE; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL; TIME; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME;

AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AREA UNDER CURVE; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSLATIONAL MEDICAL RESEARCH; TREATMENT OUTCOME;

EID: 84857096440     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-8-28     Document Type: Article

References (30)

1. Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program. Cetin K Ettinger DS, Hei YJ O'Malley CD, Clin Epidemiol 2011 3 139 148 21607015
2. 100 years of lung cancer. Pirozynski M, Respir Med 2006 100 2073 2084 10.1016/j.rmed.2006.09.002 17056245 (Pubitemid 44718401)
3. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. D'Amico TA Massey M Herndon JE Moore MB, Harpole DH Jr,, J Thorac Cardiovasc Surg 1999 117 736 743 10.1016/S0022-5223(99)70294-1 10096969 (Pubitemid 29163078)
4. Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Cerny T Barnes DM Hasleton P Barber PV, Healy K Gullick W, Thatcher N,, Br J Cancer 1986 54 265 269 10.1038/bjc.1986.172 3017396
5. Epidermal growth factor receptor inhibitors in the treatment of lung cancer: reality and hopes. Wheatley-Price P Shepherd FA, Curr Opin Oncol 2008 20 162 175 10.1097/CCO.0b013e3282f335a3 18300766 (Pubitemid 351317404)
6. Non-small-cell lung cancer. Goldstraw P Ball D Jett JR Le Chevalier T, Lim E Nicholson AG, Shepherd FA,, Lancet 2011
7. Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6. Loges S Schmidt T, Tjwa M van Geyte K, Lievens D Lutgens E, Vanhoutte D Borgel D, Plaisance S Hoylaerts M, Luttun A Dewerchin M, Jonckx B Carmeliet P, Blood 2010 115 2264 2273 10.1182/blood-2009-06-228684 19965679
8. Growth arrest-specific gene 6 expression in human breast cancer. Mc Cormack O Chung WY, Fitzpatrick P Cooke F, Flynn B Harrison M, Fox E Gallagher E, Goldrick AM Dervan PA, Mc Cann A Kerin MJ, Br J Cancer 2008 98 1141 1146 10.1038/sj.bjc.6604260 18283315 (Pubitemid 351399805)
9. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. Bingle L Brown NJ Lewis CE,, J Pathol 2002 196 254 265 10.1002/path.1027 11857487 (Pubitemid 34189413)
10. Prognostic score for patients with localized renal cell carcinoma treated by nephrectomy. Nativ O Sabo E, Madeb R Halachmi S, Madjar S Moskovitz B, Isr Med Assoc J 2001 3 24 27 11344796 (Pubitemid 34176876)
11. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Harrell FE Jr Lee KL Mark DB,, Stat Med 1996 15 361 387 10.1002/(SICI)1097-0258(19960229)15: 4<361::AID-SIM168>3.0.CO;2-4 8668867 (Pubitemid 26072233)
12. Comet-tail-like inflammatory infiltrate to polymer filaments develops in tension-free conditions. Klink CD Binnebosel M, Kaemmer D Schachtrupp A, Fiebeler A Anurov M, Schumpelick V Klinge U, Eur Surg Res 2011 46 73 81 10.1159/000322250 21196740
13. A five-gene signature and clinical outcome in non-small-cell lung cancer. Chen HY Yu SL Chen CH Chang GC, Chen CY Yuan A, Cheng CL Wang CH, Terng HJ Kao SF, Chan WK Li HN, Liu CC Singh S, Chen WJ Chen JJ, Yang PC,, N Engl J Med 2007 356 11 20 10.1056/NEJMoa060096 17202451 (Pubitemid 46041749)
14. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. Hafizi S Dahlback B, FEBS J 2006 273 5231 5244 10.1111/j.1742-4658.2006.05529.x 17064312 (Pubitemid 44772384)
15. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Sawabu T Seno H Kawashima T Fukuda A, Uenoyama Y Kawada M, Kanda N Sekikawa A, Fukui H Yanagita M, Yoshibayashi H Satoh S, Sakai Y Nakano T, Chiba T,, Mol Carcinog 2007 46 155 164 10.1002/mc.20211 17186543
16. Inflammation and cancer. Coussens LM Werb Z, Nature 2002 420 860 867 10.1038/nature01322 12490959 (Pubitemid 36019639)
17. Cancer: Inflaming metastasis. Mantovani A, Nature 2009 457 36 37 19122629
18. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Kawai O Ishii G, Kubota K Murata Y, Naito Y Mizuno T, Aokage K Saijo N, Nishiwaki Y Gemma A, Kudoh S Ochiai A, Cancer 2008 113 1387 1395 10.1002/cncr.23712 18671239
19. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Ohri CM Shikotra A Green RH Waller DA, Bradding P,, Eur Respir J 2009 33 118 126 10.1183/09031936.00065708 19118225
20. Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. Dang TP Gazdar AF, Virmani AK Sepetavec T, Hande KR Minna JD, Roberts JR Carbone DP, J Natl Cancer Inst 2000 92 1355 1357 10.1093/jnci/92.16.1355 10944559 (Pubitemid 30660597)
21. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Konishi J Kawaguchi KS Vo H Haruki N, Gonzalez A Carbone DP, Dang TP,, Cancer Res 2007 67 8051 8057 10.1158/0008-5472.CAN-07-1022 17804716 (Pubitemid 47395139)
22. Abdominal wound dehiscence in adults: development and validation of a risk model. van Ramshorst GH Nieuwenhuizen J Hop WC Arends P, Boom J Jeekel J, Lange JF,, World J Surg 2009 34 20 27
23. Reporting methods in studies developing prognostic models in cancer: a review. Mallett S Royston P Dutton S Waters R, Altman DG,, BMC Med 2010 8 20 10.1186/1741-7015-8-20 20353578
24. Renal cell carcinoma: prognostic significance of incidentally detected tumors. Tsui KH Shvarts O, Smith RB Figlin R, de Kernion JB Belldegrun A, J Urol 2000 163 426 430 10.1016/S0022-5347(05)67892-5 10647646 (Pubitemid 30060485)
25. The risk to develop a recurrence of a gastric cancer-is it independent of time? Klinge U Ackermann D, Lynen-Jansen P Mertens PR, Langenbecks Arch Surg 2008 393 149 155 10.1007/s00423-007-0272-4 18175141
26. Standardization, analytical validation, and quality control of intermediate endpoint biomarkers. Veltri RW Miller MC An G,, Urology 2001 57 164 170 10.1016/S0090-4295(00)00965-1 11295618
27. Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy. Wenske S Korets R Cronin AM Vickers AJ, Fleisher M Scher HI, Pettersson K Guillonneau B, Scardino PT Eastham JA, Lilja H,, Int J Cancer 2009 124 659 663 10.1002/ijc.23983 19003994
28. Can survival prediction be improved by merging gene expression data sets? Yasrebi H Sperisen P, Praz V Bucher P, PLoS One 2009 4 7431 10.1371/journal.pone.0007431 19851466
29. Translational disease interpretation with molecular networks. Baudot A Gomez-Lopez G Valencia A,, Genome Biol 2009 10 221 10.1186/gb-2009-10-6-221 19591646
30. Network organization of the human autophagy system. Behrends C Sowa ME, Gygi SP Harper JW, Nature 2010 466 68 76 10.1038/nature09204 20562859